←Back to Expert Scholars
Translational Medicine / 转化医学HER2 Ultra-Low
Nicholas Turner
MBBS, PhD
🏢Institute of Cancer Research / Royal Marsden🌐UK
Professor of Molecular Oncology
82
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Nicholas Turner leads translational breast cancer research at ICR with expertise in ctDNA and HER2 biology. He has contributed to DESTINY-Breast and CAPItello studies defining HER2 and AKT pathway therapeutics. His work integrates liquid biopsy into HER2 treatment monitoring.
Share:
🧪Research Fields 研究领域
ctDNA monitoring
HER2 biology
PIK3CA/AKT targeting
Translational trials
CAPItello trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Nicholas Turner 的研究动态
Follow Nicholas Turner's research updates
留下邮箱，当我们发布与 Nicholas Turner（Institute of Cancer Research / Royal Marsden）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment